Home > Journals > Minerva Obstetrics and Gynecology > Past Issues > Minerva Obstetrics and Gynecology 2022 August;74(4) > Minerva Obstetrics and Gynecology 2022 August;74(4):330-6

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Obstetrics and Gynecology 2022 August;74(4):330-6

DOI: 10.23736/S2724-606X.21.04888-0

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Estrogen and progesterone receptors in endometriosis

Luiz R. GUIMARÃES FERREIRA 1, Teresa CAVALCANTI 2, Monica ZOMER 3, William KONDO 3, Edward ARAUJO JÚNIOR 4 , Jaime KULAK JUNIOR 1

1 Department of Obstetrics and Gynecology, Federal University of Paraná (UFPR), Curitiba, Brazil; 2 Department of Pathology, Federal University of Paraná (UFPR), Curitiba, Brazil; 3 Advanced Gynecological Surgery Center, Reproduction Sector, Hospital Vita Batel, Curitiba, Brazil; 4 Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo, Brazil



BACKGROUND: This study aims to identify the presence of estrogen and progesterone hormone receptors in endometriosis implants and to determine whether hormone treatment influences the receptors in these implants.
METHODS: Cross-sectional study with historical data collection. The analysis was conducted on 156 endometriosis implants from 67 patients undergoing endometriosis laparoscopy. The patients were divided into two groups: one group underwent hormone treatment (N.=20) and another group did not receive hormone treatment (N.=47) prior to surgery. Women of reproductive age with clinical pain and/or infertility who were diagnosed with endometriosis and underwent surgery were included. The specimens were analyzed after the estrogen and progesterone hormone receptors underwent immunohistochemistry.
RESULTS: All analyzed topographies presented estrogen and progesterone hormone receptors. Progesterone hormone receptor expression was considerably superior to estrogen receptor expression (P<0.001).
CONCLUSIONS: Hormone receptors are present in endometriosis implants on the ovarian fossae, uterosacral ligaments, sac fundus, and ovaries. Progesterone receptors predominate in implants, regardless of hormonal treatment.


KEY WORDS: Endometriosis; Estrogen receptors; Progesterone receptors

top of page